China Takayasu Arteritis Registry (CTA Registry)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02964364|
Recruitment Status : Recruiting
First Posted : November 16, 2016
Last Update Posted : November 16, 2016
|Condition or disease|
|Study Type :||Observational [Patient Registry]|
|Estimated Enrollment :||1000 participants|
|Target Follow-Up Duration:||10 Years|
|Official Title:||China Takayasu Arteritis Registry (CTA Registry)|
|Study Start Date :||August 2016|
|Estimated Primary Completion Date :||July 2026|
|Estimated Study Completion Date :||July 2026|
- Mortality of the patients with TA [ Time Frame: 10 years （2016-2026） ]All-caused death at 10 years.
- The rate of the major cardiac and cerebrovascular events [ Time Frame: 10 years （2016-2026） ]the major cardiac and cerebrovascular events (MACCE) defined as the composite of all heart failure, all stroke, all myocardial infarction (MI), or any revascularization at 10 years.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02964364
|Contact: Aimin Dang, MD,PhDfirstname.lastname@example.org|
|Contact: Naqiang lv, MD,PhDemail@example.com|
|Beijing, Beijing, China, 100037|
|Contact: Naqiang Lv, Doctor +8610-88322131 firstname.lastname@example.org|
|Principal Investigator: Aimin Dang, Doctor|